Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorBalgrist University Hospital

About this trial

Effect of acute exercise testing in pregnant athletes on maternal and fetal heart rate, fetal/maternal bloodflow and cardiotocogramm assessment.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Presence of signed informed consent form

healthy pregnant active female over the age of 18 years and below 45 years

sporting activity >4h/week on 2 or more weekdays

single pregnancy, between 28+0 and 34+0 weeks of pregnancy

Disqualifiers

No signed informed consent form or revocation of consent

pre-existing pregnancy complications

Trial population

pregnant athletes

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • exercise testing

    Other intervention

    incremental cycling test on a bicycle ergometer

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

fetal heart rate

The fetal heart rate is continuously monitored via the CTG device during the entire performance test.

Time frame
through exercise testing, an average of 90 minutes

Secondary outcomes

1

Umbilical cord artery pulsatility index

(systolic velocity - diastolic velocity) / mean velocity

Time frame
through exercise testing, an average of 90 minutes
2

Umbilical cord artery resistance index

(systolic velocity - diastolic velocity) / systolic velocity

Time frame
through exercise testing, an average of 90 minutes
3

umbilical cord artery S/D ratio

(S = maximum systolic flow velocity; D = maximum diastolic flow velocity)

Time frame
through exercise testing, an average of 90 minutes
4

Medial cerebral artery pulsatility index

(systolic velocity - diastolic velocity) / mean velocity

Time frame
through exercise testing, an average of 90 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Balgrist University Hospital

Lead sponsor

University Hospital, Zürich

Collaborator